Advisory board

VTCRI advisory board President Maria Clark (right), senior vice president of Bank of America U.S. Trust Private Wealth Management, with VTCRI Executive Director Michael Friedlander (center) and advisory board member Paul Jackson of the pharmaceutical research team for Janssen Pharmaceuticals — the research and development sector of Johnson & Johnson, during a work session in Washington, D.C.

Influencers, thought-leaders in nation’s capital updated on progress at VTCRI advisory board spring meeting

Details of the biomedical research reshaping Roanoke were delivered to elected officials and university supporters in the nation’s capital recently during the Virginia Tech Carilion Research Institute Advisory Board’s spring meeting.

Spearheaded by advisory board President Maria Clarke, senior vice president of Bank of America U.S. Trust Private Wealth Management, the two-day business meeting included economic impact, branding, intellectual property, and development committee sessions at the Virginia Tech Research Center-Arlington.

The event was highlighted by an information-packed reception featuring VTCRI faculty members at the John F. Kennedy Center for the Performing Arts.

What’s more, several members of the Roanoke Symphony Orchestra led by conductor/musician David Wiley treated guests to a variety of instrumental performances.

“It is rare to host an event that presents high-level biomedical research and symphony-quality entertainment to an audience of influencers and thought-leaders,” said Michael J. Friedlander, executive director of the Virginia Tech Carilion Research Institute. “The VTCRI is gathering momentum and support from people who realize that it is a great investment toward improved health care in the nation and the elevation of Virginia in the world of biomedical research.”

The VTCRI advisory board’s fall meeting will be held in Roanoke in October.